CPA Trade Counsel Promotes Tariffs With Capitol Hill Staff
On January 31, CPA trade counsel Charles Benoit gives a masters class on the history of trade tariffs, and how they were used to build the U.S. economy.
Pharmaceuticals Are Heavily Outsourced. Can the U.S. Make More of it Here?
The U.S. is increasingly dependent on imports for drugs. One reason: a tax avoidance scheme that pits U.S. manufacturing up against Europe. What can be done about this problem?
European Pharma Considers Reshoring from India, China. Where’s the US?
The Covid-19 pandemic gave big pharma big payday. But it also caused the industry to rethink a globalized supply chain centered on Asia. What will it take to reshore at least some generic drugs to the U.S.
Supply Chain Dependence Makes Reshoring Harder – McKinsey
Can the U.S. really bring manufacturing home? A McKinsey study shows that existing concentration of some supply chains will make it hard. Here’s what needs to be done.
China’s JA Solar Sets Up Shop In Arizona as Year-Old Forced Labor Law Targets Its Supply Chain Back Home
Arizona gets $60 million solar plant. But the owner is China’s JA Solar, a company that will be in the cross hairs of forced labor laws.
Canadian Solar Panels In Maine Accused of Using China Forced Labor
Canadian Solar is mostly Chinese-run and produced. Its solar panels in a Maine government project may be tainted by forced labor.
Department of Energy Official Calls For More U.S.-Based Solar Equipment Production
A Department of Energy official warns that China’s outsized role in the solar industry is a headwind for Biden’s green energy plans, and energy security.
November Trade Deficit Falls 21% to $61.5 Billion, But $1 Trillion-Plus Deficit Record Beat
The November trade deficit fell, but that didn’t stop the U.S. from record imports this year. The goods deficit is now over $1.1 trillion.
Senate Hearing Bemoans Worker Shortages, Wonders If Reshoring Can Work
A Senate Commerce subcommittee hearing heard from witnesses who said worker shortages will ultimately be a drag on U.S. reshoring efforts. Pharmaceutical reps warned of high energy costs, which could add to import dependence.
India Drug Maker Aurobindo Keeps Getting Poor Grades by the FDA
One of India’s pharmaceutical labs has run afoul of the FDA many times this year. The U.S. is dependent on foreign labs like Aurobindo for its drug supply. Can the government help change that?
